Abiomed
ABMD
#1257
Rank
C$23.98 B
Marketcap
C$531.89
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : C$0.21 Billion

According to Abiomed's latest financial reports the company's total liabilities are C$0.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31C$0.21 B2.73%
2021-03-31C$0.20 B-2.66%
2020-03-31C$0.21 B35.6%
2019-03-31C$0.15 B25.55%
2018-03-31C$0.12 B-4.59%
2017-03-31C$0.13 B82.66%
2016-03-31C$71.65 M20.65%
2015-03-31C$59.38 M45.02%
2014-03-31C$40.95 M22.32%
2013-03-31C$33.48 M21.41%
2012-03-31C$27.57 M5.93%
2011-03-31C$26.03 M19.45%
2010-03-31C$21.79 M-13.27%
2009-03-31C$25.12 M1.37%
2008-03-31C$24.78 M51.99%
2007-03-31C$16.3 M53.17%
2006-03-31C$10.64 M79.72%
2005-03-31C$5.92 M-6.09%
2004-03-31C$6.3 M-31.26%
2003-03-31C$9.17 M-43.61%
2002-03-31C$16.27 M10.45%
2001-03-31C$14.73 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Teleflex
TFX
C$5.65 B 2,483.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$26.63 B 12,069.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
C$0.22 B 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA